Skip to main content
Erschienen in: Surgical Endoscopy 5/2021

19.05.2020

Short- and long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell cancer in patients with prior gastrectomy

verfasst von: Jia-Qi Xu, Jian-Wei Hu, Wei-Feng Chen, Mei-Dong Xu, Yun-Shi Zhong, Shi-Yao Chen, Yi-Qun Zhang, Li-Li Ma, Wen-Zheng Qin, Ming-Yan Cai, Li-Qing Yao, Ping-Hong Zhou, Quan-Lin Li

Erschienen in: Surgical Endoscopy | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

The surgery for esophageal cancer arising after prior gastrectomy is technically difficult with high morbidity and mortality. Endoscopic submucosal dissection (ESD) is a minimally invasive endoscopic treatment for superficial SCC with high curative resection rate. But few studies are concerned about ESD under these circumstances. The aim of this study was to elucidate the short- and long-term outcomes of ESD for superficial esophageal squamous cell cancer (SCC) in patients with prior gastrectomy.

Methods

From January 2009 to January 2019, 37 patients with prior gastrectomy who underwent ESD for superficial esophageal SCC were retrospectively enrolled at the Zhongshan Hospital, Fudan University in Shanghai, China. Rates of en bloc resection, complete resection, curative resection, incidence of postoperative bleeding, perforation and postoperative stricture were evaluated as short-term outcomes. Overall survival, and local recurrence-free survival were evaluated as long-term outcomes.

Results

The rate of en bloc resection, complete resection and curative resection were 94.6%, 86.5% and 78.4%, respectively. No perforation was observed. 1 (2.7%) patient experienced postoperative bleeding. During the median observation of 43 months, 3 (8.6%) patients experienced esophageal stricture, successfully managed by balloon dilation. 3(8.6%) patients had local recurrence after ESD with 5-year local recurrence-free survival rate of 91.4%. During the observation period, 4 patients died of other reasons. The 1, 3, 5-year overall survival rates were 97.1%, 97.1% and 91.4%.

Conclusions

The short-term outcomes indicate ESD is technically difficult with lower resection completeness in patients after gastrectomy, while the long-term outcomes are rather favorable.
Literatur
1.
Zurück zum Zitat Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232:225–232CrossRef Ando N, Ozawa S, Kitagawa Y, Shinozawa Y, Kitajima M (2000) Improvement in the results of surgical treatment of advanced squamous esophageal carcinoma during 15 consecutive years. Ann Surg 232:225–232CrossRef
2.
Zurück zum Zitat Wu PC, Posner MC (2003) The role of surgery in the management of oesophageal cancer. Lancet Oncol 4:481–488CrossRef Wu PC, Posner MC (2003) The role of surgery in the management of oesophageal cancer. Lancet Oncol 4:481–488CrossRef
3.
Zurück zum Zitat Luketich JD, Pennathur A, Awais O, Levy RM, Keeley S, Shende M, Christie NA, Weksler B, Landreneau RJ, Abbas G, Schuchert MJ, Nason KS (2012) Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 256:95–103CrossRef Luketich JD, Pennathur A, Awais O, Levy RM, Keeley S, Shende M, Christie NA, Weksler B, Landreneau RJ, Abbas G, Schuchert MJ, Nason KS (2012) Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 256:95–103CrossRef
4.
Zurück zum Zitat Morita M, Yoshida R, Ikeda K, Egashira A, Oki E, Sadanaga N, Kakeji Y, Yamanaka T, Maehara Y (2008) Advances in esophageal cancer surgery in Japan: an analysis of 1000 consecutive patients treated at a single institute. Surgery 143:499–508CrossRef Morita M, Yoshida R, Ikeda K, Egashira A, Oki E, Sadanaga N, Kakeji Y, Yamanaka T, Maehara Y (2008) Advances in esophageal cancer surgery in Japan: an analysis of 1000 consecutive patients treated at a single institute. Surgery 143:499–508CrossRef
5.
Zurück zum Zitat Muto M, Minashi K, Yano T, Saito Y, Oda I, Nonaka S, Omori T, Sugiura H, Goda K, Kaise M, Inoue H, Ishikawa H, Ochiai A, Shimoda T, Watanabe H, Tajiri H, Saito D (2010) Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol 28:1566–1572CrossRef Muto M, Minashi K, Yano T, Saito Y, Oda I, Nonaka S, Omori T, Sugiura H, Goda K, Kaise M, Inoue H, Ishikawa H, Ochiai A, Shimoda T, Watanabe H, Tajiri H, Saito D (2010) Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol 28:1566–1572CrossRef
6.
Zurück zum Zitat Shimizu Y, Takahashi M, Mizushima T, Ono S, Mabe K, Ohnishi S, Kato M, Asaka M, Sakamoto N (2015) Chromoendoscopy with iodine staining, as well as narrow-band imaging, is still useful and reliable for screening of early esophageal squamous cell carcinoma. Am J Gastroenterol 110:193–194CrossRef Shimizu Y, Takahashi M, Mizushima T, Ono S, Mabe K, Ohnishi S, Kato M, Asaka M, Sakamoto N (2015) Chromoendoscopy with iodine staining, as well as narrow-band imaging, is still useful and reliable for screening of early esophageal squamous cell carcinoma. Am J Gastroenterol 110:193–194CrossRef
7.
Zurück zum Zitat Pech O, May A, Manner H, Behrens A, Pohl J, Weferling M, Hartmann U, Manner N, Huijsmans J, Gossner L, Rabenstein T, Vieth M, Stolte M, Ell C (2014) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146(652–660):e1 Pech O, May A, Manner H, Behrens A, Pohl J, Weferling M, Hartmann U, Manner N, Huijsmans J, Gossner L, Rabenstein T, Vieth M, Stolte M, Ell C (2014) Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus. Gastroenterology 146(652–660):e1
8.
Zurück zum Zitat Prasad GA, Wu TT, Wigle DA, Buttar NS, Wongkeesong LM, Dunagan KT, Lutzke LS, Borkenhagen LS, Wang KK (2009) Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology 137:815–823CrossRef Prasad GA, Wu TT, Wigle DA, Buttar NS, Wongkeesong LM, Dunagan KT, Lutzke LS, Borkenhagen LS, Wang KK (2009) Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus. Gastroenterology 137:815–823CrossRef
9.
Zurück zum Zitat Zhang Y, Ding H, Chen T, Zhang X, Chen WF, Li Q, Yao L, Korrapati P, Jin XJ, Zhang YX, Xu MD, Zhou PH (2019) Outcomes of endoscopic submucosal dissection vs esophagectomy for T1 esophageal squamous cell carcinoma in a real-world cohort. Clin Gastroenterol Hepatol 17(73–81):e3 Zhang Y, Ding H, Chen T, Zhang X, Chen WF, Li Q, Yao L, Korrapati P, Jin XJ, Zhang YX, Xu MD, Zhou PH (2019) Outcomes of endoscopic submucosal dissection vs esophagectomy for T1 esophageal squamous cell carcinoma in a real-world cohort. Clin Gastroenterol Hepatol 17(73–81):e3
10.
Zurück zum Zitat Poon RT, Law SY, Chu KM, Branicki FJ, Wong J (1998) Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications. Ann Thorac Surg 65:1529–1534CrossRef Poon RT, Law SY, Chu KM, Branicki FJ, Wong J (1998) Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications. Ann Thorac Surg 65:1529–1534CrossRef
11.
Zurück zum Zitat Nagasawa S, Onda M, Sasajima K, Takubo K, Miyashita M (2000) Multiple primary malignant neoplasms in patients with esophageal cancer. Dis Esophagus 13:226–230CrossRef Nagasawa S, Onda M, Sasajima K, Takubo K, Miyashita M (2000) Multiple primary malignant neoplasms in patients with esophageal cancer. Dis Esophagus 13:226–230CrossRef
12.
Zurück zum Zitat Kudou M, Shiozaki A, Fujiwara H, Kosuga T, Konishi H, Morimura R, Murayama Y, Komatsu S, Kuriu Y, Ikoma H, Nakanishi M, Ichikawa D, Okamoto K, Sakakura C, Otsuji E (2014) Clinical analysis of esophageal cancer patients with a history of metachronous primary cancer. Gan To Kagaku Ryoho 41:2030–2032PubMed Kudou M, Shiozaki A, Fujiwara H, Kosuga T, Konishi H, Morimura R, Murayama Y, Komatsu S, Kuriu Y, Ikoma H, Nakanishi M, Ichikawa D, Okamoto K, Sakakura C, Otsuji E (2014) Clinical analysis of esophageal cancer patients with a history of metachronous primary cancer. Gan To Kagaku Ryoho 41:2030–2032PubMed
13.
Zurück zum Zitat Baba Y, Yoshida N, Kinoshita K, Iwatsuki M, Yamashita YI, Chikamoto A, Watanabe M, Baba H (2018) Clinical and prognostic features of patients with esophageal cancer and multiple primary cancers: a retrospective single-institution study. Ann Surg 267:478–483CrossRef Baba Y, Yoshida N, Kinoshita K, Iwatsuki M, Yamashita YI, Chikamoto A, Watanabe M, Baba H (2018) Clinical and prognostic features of patients with esophageal cancer and multiple primary cancers: a retrospective single-institution study. Ann Surg 267:478–483CrossRef
14.
Zurück zum Zitat Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam JB, Smythe WR, Feig BW, Mansfield PF, Pisters PW, Torres MT, Walsh GL (2005) Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction. J Thorac Cardiovasc Surg 130:1391–1398CrossRef Ascioti AJ, Hofstetter WL, Miller MJ, Rice DC, Swisher SG, Vaporciyan AA, Roth JA, Putnam JB, Smythe WR, Feig BW, Mansfield PF, Pisters PW, Torres MT, Walsh GL (2005) Long-segment, supercharged, pedicled jejunal flap for total esophageal reconstruction. J Thorac Cardiovasc Surg 130:1391–1398CrossRef
15.
Zurück zum Zitat Motoyama S, Kitamura M, Saito R, Maruyama K, Sato Y, Hayashi K, Saito H, Minamiya Y, Ogawa J (2007) Surgical outcome of colon interposition by the posterior mediastinal route for thoracic esophageal cancer. Ann Thorac Surg 83:1273–1278CrossRef Motoyama S, Kitamura M, Saito R, Maruyama K, Sato Y, Hayashi K, Saito H, Minamiya Y, Ogawa J (2007) Surgical outcome of colon interposition by the posterior mediastinal route for thoracic esophageal cancer. Ann Thorac Surg 83:1273–1278CrossRef
16.
Zurück zum Zitat Shiryajev YN (2013) Use of the remnant stomach for oesophagoplasty in patients following distal gastrectomy. Eur J Cardiothorac Surg 43:9–18CrossRef Shiryajev YN (2013) Use of the remnant stomach for oesophagoplasty in patients following distal gastrectomy. Eur J Cardiothorac Surg 43:9–18CrossRef
17.
Zurück zum Zitat Okumura H, Mori N, Tanaka T, Morita M, Toh Y, Saeki H, Maehara Y, Nakamura K, Honda H, Yoshida N, Baba H, Natsugoe S (2016) Clinical features and treatment of patients with esophageal cancer and a history of gastrectomy: a multicenter, questionnaire survey in Kyushu, Japan. Dis Esophagus 29:1135–1143CrossRef Okumura H, Mori N, Tanaka T, Morita M, Toh Y, Saeki H, Maehara Y, Nakamura K, Honda H, Yoshida N, Baba H, Natsugoe S (2016) Clinical features and treatment of patients with esophageal cancer and a history of gastrectomy: a multicenter, questionnaire survey in Kyushu, Japan. Dis Esophagus 29:1135–1143CrossRef
18.
Zurück zum Zitat Koide Y, Kodaira T, Tachibana H, Tomita N, Makita C, Itoh M, Abe T, Muro K, Tajika M, Niwa Y, Itoh Y, Naganawa S (2017) Clinical outcome of definitive radiation therapy for superficial esophageal cancer. Jpn J Clin Oncol 47:393–400CrossRef Koide Y, Kodaira T, Tachibana H, Tomita N, Makita C, Itoh M, Abe T, Muro K, Tajika M, Niwa Y, Itoh Y, Naganawa S (2017) Clinical outcome of definitive radiation therapy for superficial esophageal cancer. Jpn J Clin Oncol 47:393–400CrossRef
19.
Zurück zum Zitat Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Herr JP, Paillot B, Arveux P, Bonnetain F, Binquet C (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160–1168CrossRef Bedenne L, Michel P, Bouche O, Milan C, Mariette C, Conroy T, Pezet D, Roullet B, Seitz JF, Herr JP, Paillot B, Arveux P, Bonnetain F, Binquet C (2007) Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. J Clin Oncol 25:1160–1168CrossRef
20.
Zurück zum Zitat Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317CrossRef Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, Klump B, Budach W, Teichmann R, Schmitt M, Schmitt G, Franke C, Wilke H (2005) Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 23:2310–2317CrossRef
21.
Zurück zum Zitat Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano H, Takeuchi H, Toh Y, Doki Y, Naomoto Y, Nemoto K, Booka E, Matsubara H, Miyazaki T, Muto M, Yanagisawa A, Yoshida M (2019) Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2. Esophagus 16:25–43CrossRef Kitagawa Y, Uno T, Oyama T, Kato K, Kato H, Kawakubo H, Kawamura O, Kusano M, Kuwano H, Takeuchi H, Toh Y, Doki Y, Naomoto Y, Nemoto K, Booka E, Matsubara H, Miyazaki T, Muto M, Yanagisawa A, Yoshida M (2019) Esophageal cancer practice guidelines 2017 edited by the Japan esophageal society: part 2. Esophagus 16:25–43CrossRef
22.
Zurück zum Zitat Takahashi H, Arimura Y, Masao H, Okahara S, Tanuma T, Kodaira J, Kagaya H, Shimizu Y, Hokari K, Tsukagoshi H, Shinomura Y, Fujita M (2010) Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 72:255–264CrossRef Takahashi H, Arimura Y, Masao H, Okahara S, Tanuma T, Kodaira J, Kagaya H, Shimizu Y, Hokari K, Tsukagoshi H, Shinomura Y, Fujita M (2010) Endoscopic submucosal dissection is superior to conventional endoscopic resection as a curative treatment for early squamous cell carcinoma of the esophagus (with video). Gastrointest Endosc 72:255–264CrossRef
23.
Zurück zum Zitat Ono S, Fujishiro M, Niimi K, Goto O, Kodashima S, Yamamichi N, Omata M (2009) Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc 70:860–866CrossRef Ono S, Fujishiro M, Niimi K, Goto O, Kodashima S, Yamamichi N, Omata M (2009) Long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell neoplasms. Gastrointest Endosc 70:860–866CrossRef
24.
Zurück zum Zitat Repici A, Hassan C, Carlino A, Pagano N, Zullo A, Rando G, Strangio G, Romeo F, Nicita R, Rosati R, Malesci A (2010) Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma: results from a prospective Western series. Gastrointest Endosc 71:715–721CrossRef Repici A, Hassan C, Carlino A, Pagano N, Zullo A, Rando G, Strangio G, Romeo F, Nicita R, Rosati R, Malesci A (2010) Endoscopic submucosal dissection in patients with early esophageal squamous cell carcinoma: results from a prospective Western series. Gastrointest Endosc 71:715–721CrossRef
25.
Zurück zum Zitat Takahashi R, Yoshio T, Horiuchi Y, Omae M, Ishiyama A, Hirasawa T, Yamamoto Y, Tsuchida T, Fujisaki J (2017) Endoscopic tissue shielding for esophageal perforation caused by endoscopic resection. Clin J Gastroenterol 10:214–219CrossRef Takahashi R, Yoshio T, Horiuchi Y, Omae M, Ishiyama A, Hirasawa T, Yamamoto Y, Tsuchida T, Fujisaki J (2017) Endoscopic tissue shielding for esophageal perforation caused by endoscopic resection. Clin J Gastroenterol 10:214–219CrossRef
26.
Zurück zum Zitat Chu Y, Chen T, Li H, Zhou P, Zhang Y, Chen W, Zhong Y, Yao L, Xu M (2019) Long-term efficacy and safety of intralesional steroid injection plus oral steroid administration in preventing stricture after endoscopic submucosal dissection for esophageal epithelial neoplasms. Surg Endosc 33:1244–1251CrossRef Chu Y, Chen T, Li H, Zhou P, Zhang Y, Chen W, Zhong Y, Yao L, Xu M (2019) Long-term efficacy and safety of intralesional steroid injection plus oral steroid administration in preventing stricture after endoscopic submucosal dissection for esophageal epithelial neoplasms. Surg Endosc 33:1244–1251CrossRef
27.
Zurück zum Zitat Saito Y, Tanaka T, Andoh A, Minematsu H, Hata K, Tsujikawa T, Nitta N, Murata K, Fujiyama Y (2008) Novel biodegradable stents for benign esophageal strictures following endoscopic submucosal dissection. Dig Dis Sci 53:330–333CrossRef Saito Y, Tanaka T, Andoh A, Minematsu H, Hata K, Tsujikawa T, Nitta N, Murata K, Fujiyama Y (2008) Novel biodegradable stents for benign esophageal strictures following endoscopic submucosal dissection. Dig Dis Sci 53:330–333CrossRef
28.
Zurück zum Zitat Ohki T, Yamato M, Murakami D, Takagi R, Yang J, Namiki H, Okano T, Takasaki K (2006) Treatment of oesophageal ulcerations using endoscopic transplantation of tissue-engineered autologous oral mucosal epithelial cell sheets in a canine model. Gut 55:1704–1710CrossRef Ohki T, Yamato M, Murakami D, Takagi R, Yang J, Namiki H, Okano T, Takasaki K (2006) Treatment of oesophageal ulcerations using endoscopic transplantation of tissue-engineered autologous oral mucosal epithelial cell sheets in a canine model. Gut 55:1704–1710CrossRef
29.
Zurück zum Zitat Cheng BC, Xia J, Shao K, Mao ZF, Huang J, Wang TS (2005) Surgical treatment for upper or middle esophageal carcinoma occurring after gastrectomy: a study of 52 cases. Dis Esophagus 18:239–245CrossRef Cheng BC, Xia J, Shao K, Mao ZF, Huang J, Wang TS (2005) Surgical treatment for upper or middle esophageal carcinoma occurring after gastrectomy: a study of 52 cases. Dis Esophagus 18:239–245CrossRef
30.
Zurück zum Zitat Doki Y, Okada K, Miyata H, Yamasaki M, Fujiwara Y, Takiguchi S, Yasuda T, Hirao T, Nagano H, Monden M (2008) Long-term and short-term evaluation of esophageal reconstruction using the colon or the jejunum in esophageal cancer patients after gastrectomy. Dis Esophagus 21:132–138CrossRef Doki Y, Okada K, Miyata H, Yamasaki M, Fujiwara Y, Takiguchi S, Yasuda T, Hirao T, Nagano H, Monden M (2008) Long-term and short-term evaluation of esophageal reconstruction using the colon or the jejunum in esophageal cancer patients after gastrectomy. Dis Esophagus 21:132–138CrossRef
31.
Zurück zum Zitat Berger A, Rahmi G, Perrod G, Pioche M, Canard JM, Cesbron-Metivier E, Boursier J, Samaha E, Vienne A, Lepilliez V, Cellier C (2019) Long-term follow-up after endoscopic resection for superficial esophageal squamous cell carcinoma: a multicenter western study. Endoscopy 51:298–306CrossRef Berger A, Rahmi G, Perrod G, Pioche M, Canard JM, Cesbron-Metivier E, Boursier J, Samaha E, Vienne A, Lepilliez V, Cellier C (2019) Long-term follow-up after endoscopic resection for superficial esophageal squamous cell carcinoma: a multicenter western study. Endoscopy 51:298–306CrossRef
32.
Zurück zum Zitat Uno K, Koike T, Kusaka G, Takahashi Y, Ara N, Shimosegawa T (2017) Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma. Dis Esophagus 30:1–8CrossRef Uno K, Koike T, Kusaka G, Takahashi Y, Ara N, Shimosegawa T (2017) Risk of metachronous recurrence after endoscopic submucosal dissection of esophageal squamous cell carcinoma. Dis Esophagus 30:1–8CrossRef
Metadaten
Titel
Short- and long-term outcomes of endoscopic submucosal dissection for superficial esophageal squamous cell cancer in patients with prior gastrectomy
verfasst von
Jia-Qi Xu
Jian-Wei Hu
Wei-Feng Chen
Mei-Dong Xu
Yun-Shi Zhong
Shi-Yao Chen
Yi-Qun Zhang
Li-Li Ma
Wen-Zheng Qin
Ming-Yan Cai
Li-Qing Yao
Ping-Hong Zhou
Quan-Lin Li
Publikationsdatum
19.05.2020
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 5/2021
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-020-07636-y

Weitere Artikel der Ausgabe 5/2021

Surgical Endoscopy 5/2021 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.